Akkermansia muciniphila
Akkermansia muciniphila is a gut-associated bacterium studied for its interactions with host tissues, microbial metabolites, and immune and metabolic pathways.
Akkermansia muciniphila is a gut-associated bacterium studied for its interactions with host tissues, microbial metabolites, and immune and metabolic pathways. Its reported research roles span carbohydrate recognition, intestinal barrier function, insulin sensitivity, glucose tolerance, inflammation, and host–microbiota signaling. A recently characterized family 32 carbohydrate-binding module associated with AmGH123, AmGH123CBM32, binds ganglioside-associated glycans and represents the first characterized carbohydrate-binding module from A. muciniphila.
The organism and its pasteurized preparation MucT have also been investigated in metabolic, neurological, inflammatory, and cancer-related contexts. In obese and prediabetic adults, pasteurized MucT was examined for effects on insulin sensitivity, body composition, GLP-1 production, and barrier function. Experimental studies have associated A. muciniphila with improved recovery after ischemic stroke, reduced depression-like behavior, attenuation of diabetic cognitive impairment through effects on the NLRP3 inflammasome and hippocampal synapses, and amelioration of chronic pancreatitis. Other work has examined its relationship with breast-tissue microbiota and oxidative stress, while microbiome-based cancer research has considered its potential contribution to IL-12 production, Th1 polarization, and CD8+ T-cell responses during checkpoint blockade.
Where the papers sit
9 papers from the last 6 months study akkermansia muciniphila directly · updated from PubMed 12 Nov 2026
Study type 2 clinical trials · 6 preclinical · 1 unclassified
Themes one subject · 1 new direction
Those 9 are all about one subject.
-
Akkermansia Health Research
Strain characterization and probiotic testing frame Akkermansia as a candidate for metabolic and disease-modifying interventions. Studies link supplementation or higher tissue abundance to insulin sensitivity, GLP-1 production, obesity, neuroinflammation, cognitive impairment, depression-like behavior and colorectal-cancer immunotherapy. Mechanistic signals include ganglioside-glycan binding, NLRP3 inhibition and altered macrophage efferocytosis, while disease-associated abundance may also promote oxidative stress and breast-cancer risk. The evidence remains preclinical or early clinical and is not yet directionally consistent.
Mammary-tissue Akkermansia muciniphila is a tumor-promoting, rather than health-promoting, factor in obesity-associated breast cancer
The obesity- and age-associated breast cancer study in postmenopausal women and MMTV-PyMT mice found that elevated mammary-gland A. muciniphila increased oxidative stress, tumorigenesis, and tumor multiplicity, while N-acetylcysteine reduced this effect 42423461Jul. This departs from the set’s otherwise therapeutic or beneficial framing of A. muciniphila by assigning it a tissue-resident, disease-promoting role: in the mammary gland, its elevation may contribute to cancer risk rather than protect against metabolic, inflammatory, or neurological disease.
Papers
The 9 papers from the last 6 months that study akkermansia muciniphila directly, newest first, by theme and by study type. Study types come from PubMed publication types and MeSH headings.
By theme
Akkermansia Health Research (9)
- Genomic and probiotic characterization of newly isolated Akkermansia strains from camel and horse feces in alleviating obesity and metabolic dysregulation. World journal of microbiology & biotechnology · 6 Nov 2026 PMID 42993212
- Characterization of a Unique Carbohydrate-Binding Module from Akkermansia muciniphila that Binds Ganglioside-Associated Glycans. Biochemistry · 3 Nov 2026 PMID 42975160
- A microbiota-metabolite-glial axis drives white matter repair via isorhamnetin-PSAP-GPR37 signaling after ischemic stroke. Gut microbes · 1 Nov 2026 PMID 42968220
- Akkermansia muciniphila attenuates macrophage efferocytosis to enhance anti-PD-1 efficacy in microsatellite-stable colorectal cancer. Cell host & microbe · 16 Oct 2026 PMID 42887494
- HtpG-High-Expressing Escherichia coli Promotes Fibrosis in Chronic Pancreatitis. Gastroenterology · 13 Oct 2026 PMID 42869256
- Akkermansia muciniphila gavage alleviates depression-like behaviors in female A53T α-synuclein transgenic mice. Behavioural brain research · 7 Aug 2026 PMID 42567327
- Obesity and Age Elevate Tissue-Resident Microbiota Akkermansia muciniphila to Induce Oxidative Stress and Promote Breast Cancer Risk. Cancer research · 9 Jul 2026 PMID 42423461
- Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels. Gut microbes · 25 Jun 2026 PMID 42343233
- Akkermansia muciniphila alleviates diabetic cognitive impairment by inhibiting NLRP3 inflammasome activation and ameliorating hippocampal synaptic defects. Food & function · 16 Jun 2026 PMID 42300325
By study type
Clinical trials (2)
- Akkermansia muciniphila attenuates macrophage efferocytosis to enhance anti-PD-1 efficacy in microsatellite-stable colorectal cancer. Cell host & microbe · 16 Oct 2026 PMID 42887494
- Effect of pasteurized Akkermansia muciniphila MucT on insulin sensitivity, body composition, and GLP-1 production in subjects with metabolic syndrome: impact of low baseline gut Akkermansia levels. Gut microbes · 25 Jun 2026 PMID 42343233
Preclinical: animal, cell and lab studies (6)
- Genomic and probiotic characterization of newly isolated Akkermansia strains from camel and horse feces in alleviating obesity and metabolic dysregulation. World journal of microbiology & biotechnology · 6 Nov 2026 PMID 42993212
- Characterization of a Unique Carbohydrate-Binding Module from Akkermansia muciniphila that Binds Ganglioside-Associated Glycans. Biochemistry · 3 Nov 2026 PMID 42975160
- A microbiota-metabolite-glial axis drives white matter repair via isorhamnetin-PSAP-GPR37 signaling after ischemic stroke. Gut microbes · 1 Nov 2026 PMID 42968220
- Akkermansia muciniphila gavage alleviates depression-like behaviors in female A53T α-synuclein transgenic mice. Behavioural brain research · 7 Aug 2026 PMID 42567327
- Obesity and Age Elevate Tissue-Resident Microbiota Akkermansia muciniphila to Induce Oxidative Stress and Promote Breast Cancer Risk. Cancer research · 9 Jul 2026 PMID 42423461
- Akkermansia muciniphila alleviates diabetic cognitive impairment by inhibiting NLRP3 inflammasome activation and ameliorating hippocampal synaptic defects. Food & function · 16 Jun 2026 PMID 42300325
Unclassified: not yet indexed with MeSH (1)
- HtpG-High-Expressing Escherichia coli Promotes Fibrosis in Chronic Pancreatitis. Gastroenterology · 13 Oct 2026 PMID 42869256
Written from 9 PubMed abstracts, each one listed by PMID above. Published: 2026-11-05. Drafted by language models from published abstracts; not medical advice.